Xencor, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Quarterly reports show how much money the company makes and spends, helping investors track progress.
Companies announce earnings regularly so investors know if the business is growing or shrinking.
Getting $105 million in cash helps the company fund research and operations, boosting its financial strength.
Directors make big decisions and an equity plan lets employees own company stock, aligning their goals with investors.
Quarterly reports show how much money the company makes and spends, helping investors track progress.
Companies announce earnings regularly so investors know if the business is growing or shrinking.
Drug development updates show progress on potential medicines, which affects whether the company succeeds long-term.
Stocky reads Xencor, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Xencor, Inc.'s most recent tracked filing was a 10-Q on 5 Aug 2026: Files second quarter 2026 financial results.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.